Balancing benefits and harms in a randomized clinical trial through modeling expected health over time – a secondary analysis of SPRINT comparing blood pressure targets
| Autor: | Aschmann, H, Puhan, M |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Nützliche patientenrelevante Forschung; 21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin; 20200213-20200215; Basel, Schweiz; DOC20ebmS6-V1-02 /20200212/ |
| DOI: | 10.3205/20ebm036 |
| Popis: | Background/research question: When the results of randomized clinical trials are reported, there is a focus on the primary outcome, typically a measure of the efficacy of an intervention, i.e. the benefit. Harms or side effects are typically reported as secondary outcomes. An interpretation of [for full text, please go to the a.m. URL] Nützliche patientenrelevante Forschung; 21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|